Who owns PELTHOS THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Pelthos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pelthos Therapeutics stock

Who bought or sold PELTHOS THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
AIGH Capital Management 329k $9.3M 100% Jun 2026
 View chart
Murchinson 304k $8.6M 3% Jun 2026
 View chart
Ikarian Capital 257k $7.3M 0% Jun 2026
 View chart
Boothbay Fund Management 102k $2.9M 25% Jun 2026
 View chart
Vanguard Capital Management 97k $2.7M 4% Jun 2026
 View chart
Cantor Fitzgerald, L. P. 38k $1.1M -8% Jun 2026
 View chart
J. Goldman & Co 38k $1.1M -24% Jun 2026
 View chart
Diadema Partners 25k $700k 0% Jun 2026
 View chart
Wexford Capital 22k $632k 100% Jun 2026
 View chart
Knott David M Jr 22k $624k 5% Jun 2026
 View chart
Citadel Advisors 15k $425k 100% Jun 2026
 View chart
Geode Capital Management 15k $414k -4% Jun 2026
 View chart
Pale Fire Capital SE 13k $365k 0% Jun 2026
 View chart
1492 Capital Management 10k $293k 100% Jun 2026
 View chart
Vanguard Fiduciary Trust 9.9k $279k 1% Jun 2026
 View chart
Persistent Asset Partners 6.0k $170k 0% Jun 2026
 View chart
BlackRock 5.3k $151k 100% Jun 2026
 View chart
UBS Group 2.2k $63k 190% Jun 2026
 View chart
China Universal Asset Management 2.2k $61k 100% Jun 2026
 View chart
Tower Research Capital 205.00 $5.8k 100% Jun 2026
 View chart
Farther Finance Advisors 40.00 $1.1k 0% Jun 2026
 View chart
Barclays 20.00 $565.000000 100% Jun 2026
 View chart
Royal Bank of Canada 6.00 $0 100% Jun 2026
 View chart
Citigroup 1.00 $21.000000 100% Mar 2026
 View chart

Who sold out of Pelthos Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Steward Partners Investment Advisory Mar 2026 1.9k $40k
Aspect Partners Mar 2026 16.00 $336.000000